New Drug Advances the Fight Against Pancreatic Cancer

May 12, 2011

USA Today

For the first time in years, doctors are making progress against pancreatic cancer, one of the deadliest of all tumors, which kills all but 6% of patients. Although there is still no cure, a new drug combination can help patients live months longer than on standard therapy. And other studies already underway may soon offer patients even more options, researchers say. Patients taking Folfirinox, a novel combination of four drugs already approved to fight other cancers, lived 11.1 months — 4.3 months longer than those given standard chemo, according to a French study of 342 patients in today's New England Journal of Medicine... Read More